Recent

% | $
Quotes you view appear here for quick access.

NanoLogix, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • phloam131314 phloam131314 Jul 14, 2011 10:50 PM Flag

    Interview Transcript

    continued:



    Paul: What other developments do you have?

    Bret: Well the BNF ... there's a second type of technology that gives spot-on antibody and antigen reaction, and then with buffering it is only for live cells. And it can give results, from what we've seen, for the trails that are going on, or the trial that is going on at the University of Texas Health Science Center in Houston for Group-B Streptococcus in anywhere from ... well, they've seen results in as early as 2 hours. Dependable results in 6 hours .... where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours. As opposed to 48 to 72 hours with the traditional methods that are dictated by the CDC. So we're very excited about that. Now, what we see for the future is researchers at one bio-defense company, and the aforementioned clinical trail that's going on for Group-B Strep in Houston, should have 3 to 5 papers published this year. And then we're also in a clinical trial for Group-B Strep in Italy with one of the ... probably the leading doctor for infectious diseases for OBGYN. And he believes that he'll be published this year also. So we should have multiple papers published in a number of journals. And I can't .... one's been accepted so far for publication in a very established US journal and I can't reveal that, right now, what the name is. But it should be out within a couple of months. So we see that, and then a lot of interest when we just had ... the NAVY's just submitted a request for an order for BNF kits, and that's a big deal to us, because little outfits like the NAVY don't need FDA approval for use ... just like the EPA ... we work with the EPA on developing a comprehensive water quality test kit for use in all 10 EPA regions, and once that developed they don't need any approval other than their own. So we're pretty excited about all that.

    Paul: Well we certainly hope that you continue to work with the drug industry as well, and we'll check back with you in six months or a year and see how things are going. Bret, thanks so much for talking with us today.

    Bret: You're welcome Paul.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Phloam, thanks for doing that. I just love how Bret says "little outfits like the Navy don't need FDA approval for use..." Classic stuff.

      Obviously from all this, one should be able to gather the company is heading in the right direction for sure. It does suck the stock price is what it is from where it once was briefly, but I get the feeling the PPS could explode upward at some point. Things are looking strong IMO and I rather own stock right now in this company then be on the sidelines no matter what the market cap is. In reality it is only .35c a share and you could build a healthy supply of NNLX stock at this point. Just my IMO.

    • I posted this back in March:
      Jason and War- the other day I was sitting next to an young lady who in chit chat I found works for the Navy taking specimens and specifically identifying E.coli from patients. I asked if they used petri dished and she said yes, then I asked how long they wait for results and she said "not that long, just overnight." What if you could get results in 4 hours, I asked. She said "Awesome!! Then I could finish all my samples in one day!"
      With that I whipped out my iPad and showed her the Nanologix site and she was all Wow!! And started writing some notes down right away.
      I still believe it is simply a matter of time until the test kits gain traction in the marketplace.

      As we now see the Navy does see the validity of and is interested in NanoLogix products. Sweet!!!

    • Phloam

      I think the most important statement in that interview, which once stated in these upcoming papers will establish a new "gold standard" in culture testing which will eventually get this bad boy a'moven brother!

      <<< where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours.>>>


      Hapy Friday people!
      Andre

    • Petro does this sound like Clinical trial is going on in Europe ?

      <<Paul: What other developments do you have?

      Bret: Well the BNF ... there's a second type of technology that gives spot-on antibody and antigen reaction, and then with buffering it is only for live cells. And it can give results, from what we've seen, for the trails that are going on, or the trial that is going on at the University of Texas Health Science Center in Houston for Group-B Streptococcus in anywhere from ... well, they've seen results in as early as 2 hours. Dependable results in 6 hours .... where results are detection of the bacteria, specific identification of the bacteria, and determination of antibiotic sensitivity all within 6 hours. As opposed to 48 to 72 hours with the traditional methods that are dictated by the CDC. So we're very excited about that. Now, what we see for the future is researchers at one bio-defense company, and the aforementioned clinical trail that's going on for Group-B Strep in Houston, should have 3 to 5 papers published this year. And then we're also in a clinical trial for Group-B Strep in Italy with one of the ... probably the leading doctor for infectious diseases for OBGYN. And he believes that he'll be published this year also. So we should have multiple papers published in a number of journals>

    • Interesting read. Closing in on a year.

    • View More Messages
 
NNLX
0.029Jul 31 12:24 PMEDT